COLO-PREDICT: Digital Training and Optical Diagnosis of Colorectal Polyps
Recruiting
Observational Study
Colorectal Polyps
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Clinique Paris-Bercy · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Colorectal cancer prevention relies on high-quality colonoscopy and accurate optical characterization of colorectal polyps. Optical diagnosis may allow optimization of management strategies such as resect-and-discard for diminutive polyps, potentially improving efficiency in routine practice.
COLO-PREDICT is a prospective, single-center, observational study designed to evaluate the impact of a st…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged ≥18 years
* Patients undergoing colonoscopy in routine clinical practice at the participating center
* At least one colorectal polyp detected during colonoscopy
* Optical histology prediction recorded during the procedure
* Histopathological analysis available for …
Contacts